Moderna
MRNA
#1058
Rank
A$30.97 B
Marketcap
A$78.44
Share price
1.80%
Change (1 day)
46.27%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -A$4.97 Billion

According to Moderna 's latest financial reports the company's current earnings are A$2.20 Billion. In 2024 the company made an earning of -A$5.03 Billion, an increase over its 2023 earnings that were of -A$5.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.97 Billion-1.19%
2024 -A$5.03 Billion-8.22%
2023 -A$5.48 Billion-140.65%
2022 A$13.46 B-27.81%
2021 A$18.64 B-1911.15%
2020 -A$1.03 Billion44.7%
2019 -A$0.72 Billion28.63%
2018 -A$0.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.40 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.91 B-619.94%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$32.36 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-A$66.48 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$58.53 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.18 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$0.19 B-104.48%๐Ÿ‡บ๐Ÿ‡ธ USA